The FDA announced good news yesterday when they changed the guidelines for taking Mifeprex, the brand name for the pill used in medication abortions. The updated labeling actually reflects how health care providers have been prescribing the medication for years and allows women to take the pill later in pregnancy and requires fewer visits to the health care provider. More
Our Bodies, Our Blog
As infertility treatments expand, more and more women are donating their eggs. Unfortunately, little is known about the long-term safety of egg donation. OBOS’s Judy Norsigian and Dr. Timothy Johnson explore why this is true and what can be done to encourage more research. More
Talking openly and honestly with young women about sex, pleasure, and trust not only leads to healthier decision making but allows young women to feel more comfortable with their bodies and their sexual pleasure. More
The Supreme Court will hear arguments on religiously affiliated organizations’ objections to the ACA’s contraceptive coverage mandate. Although there is accommodation for groups to opt-out, some organizations still find the process “morally objectionable.” More
What’s Behind the Increased Numbers of Black Women Dying During Pregnancy and Childbirth in the United States?
New OBOS blogger Amie Newman explores why black women in the United States are dying during pregnancy, childbirth, and the year following childbirth at nearly four times the rate of white women. While poor women are at greater risk of dying than women who have higher incomes, the disparity between black and white women is consistent at all income levels. More
Josephine Cristobal writes about how Obama’s 2017 proposed budget cuts the last vestiges of federal funding for abstinence-only-until-marriage sex education. More
About one in a million women who have an early abortion die, while one in 50,000 women who have cosmetic surgery die. Diana Zuckerman asks why states are “protecting” women from one but not the other? More
Zoe Greenberg looks at anti-abortion activists who are determined to end fetal tissue research, and shows how their efforts risk slowing down research aimed at understanding and eradicating many diseases.